Mayne Pharma Group Ltd
(OTCPK:MAYNF)
$
2.988
-0.123 (-3.95%)
Market Cap: 250.89 Mil
Enterprise Value: 182.47 Mil
PE Ratio: 0
PB Ratio: 0.66
GF Score: 56/100 Mayne Pharma Group Ltd (MAYNF) Transcripts
- Half Year 2024 Mayne Pharma Group Ltd Earnings Call TranscriptFeb 25, 2024Earnings
- Mayne Pharma Group Ltd at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Mayne Pharma Group Ltd Annual Shareholders Meeting TranscriptNov 29, 2023
- Q1 2024 Mayne Pharma Group Ltd Market Update Call TranscriptOct 17, 2023
- Full Year 2023 Mayne Pharma Group Ltd Earnings Call TranscriptAug 30, 2023$2.95Earnings
- Mayne Pharma Group Ltd at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Mayne Pharma Group Ltd Investor Update Call TranscriptMay 09, 2023
- Half Year 2023 Mayne Pharma Group Ltd Earnings Call TranscriptFeb 27, 2023$2.05 (+2.50%)Earnings
- Mayne Pharma Group Ltd Annual Shareholders Meeting TranscriptNov 29, 2022
- Full Year 2022 Mayne Pharma Group Ltd Earnings Call TranscriptAug 25, 2022$4.74 (-1.90%)Earnings
- Half Year 2022 Mayne Pharma Group Ltd Earnings Call TranscriptFeb 24, 2022$3.67 (-2.13%)Earnings
- Mayne Pharma Group Ltd Annual Shareholders Meeting TranscriptNov 22, 2021
- Full Year 2021 Mayne Pharma Group Ltd Earnings Presentation TranscriptAug 26, 2021
- Half Year 2021 Mayne Pharma Group Ltd Earnings Presentation TranscriptFeb 23, 2021
- Mayne Pharma Group Ltd Annual Shareholders Meeting TranscriptNov 23, 2020
- Full Year 2020 Mayne Pharma Group Ltd Earnings Call TranscriptAug 20, 2020$5.24 (+2.79%)Earnings
- Half Year 2020 Mayne Pharma Group Ltd Earnings Presentation TranscriptFeb 20, 2020
- Full Year 2019 Mayne Pharma Group Ltd Earnings Presentation TranscriptAug 23, 2019
- Q3 2019 Mayne Pharma Group Ltd Trading Update Call TranscriptMay 14, 2019
- Half Year 2019 Mayne Pharma Group Ltd Earnings Presentation TranscriptFeb 21, 2019
- 1